Proprotein Convertase Subtilisin/kexin Type 9 Gene E670G Polymorphism Interacts with Alcohol Consumption to Modulate Serum Lipid Levels

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2013 Jan 19

PMID 23329883

Citations 9

Authors

Lynn Htet Htet Aung

Rui-Xing Yin

Dong-Feng Wu

Xiao-Li Cao

Xi-Jiang Hu

Lin Miao

Affiliations

Soon will be listed here.

Abstract

Background: Both alcohol consumption and the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene polymorphism modulate serum lipid levels, but their interactions on serum lipid profiles are still unknown. The present study was undertaken to detect the interactions of PCSK9 E670G polymorphism and alcohol consumption on serum lipid levels.

Methods: Genotypes of the PCSK9 E670G in 1352 unrelated subjects (785 non-drinkers and 567 drinkers) were determined by polymerase chain reaction and restriction fragment length polymorphism combined with gel electrophoresis, and then confirmed by direct sequencing. The interactions between PCSK9 E670G genotypes and alcohol consumption on serum lipid parameters were detected by using a factorial design covariance analysis after controlling for potential confounders.

Results: The levels of serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein (Apo) A1, and the ratio of ApoA1 to ApoB were higher in drinkers than in non-drinkers (P < 0.01 for all), whereas the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and ApoB were lower in drinkers than in non-drinkers (P < 0.001 for all). The genotypic and allelic frequencies of PCSK9 E670G were not different between non-drinkers and drinkers (P > 0.05 for each). The subjects with AA genotype in non-drinkers had higher serum LDL-C levels than the subjects with AG genotype, whereas the subjects with AG genotype in drinkers had higher serum TC levels than the subjects with AA genotypes (P < 0.05 for each). The effects of alcohol consumption on TC and LDL-C levels depended upon genotypes, the subjects with AA genotype had lower serum TC and LDL-C levels in drinkers than in non-drinkers.

Conclusions: Alcohol consumption can modify the effects of the PCSK9 E670G polymorphism on serum TC and LDL-C levels. The subjects with AA genotype of the PCSK9 E670G benefit more from alcohol consumption than the subjects with AG genotype in decreasing serum TC and LDL-C levels.

Citing Articles

Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population.

Hamamura H, Adachi H, Enomoto M, Fukami A, Nakamura S, Nohara Y J Atheroscler Thromb. 2020; 28(4):329-337.

PMID: 32624555 PMC: 8147011. DOI: 10.5551/jat.56390.

The association of the rs16955379 polymorphism with dyslipidemia and the clinicopathological features of IgA nephropathy.

Mo M, Pan L, Lu Q, Li Q, Liao Y Int J Clin Exp Pathol. 2020; 11(10):5008-5023.

PMID: 31949578 PMC: 6962923.

Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population.

Cai G, Yu L, Huang Z, Li L, Fu X Lipids Health Dis. 2018; 17(1):213.

PMID: 30205809 PMC: 6134597. DOI: 10.1186/s12944-018-0859-5.

What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.

Qiu C, Zeng P, Li X, Zhang Z, Pan B, Peng Z Lipids Health Dis. 2017; 16(1):111.

PMID: 28606094 PMC: 5469167. DOI: 10.1186/s12944-017-0506-6.

Association of the ARL15 rs6450176 SNP and serum lipid levels in the Jing and Han populations.

Sun J, Yin R, Shi G, Shen S, Chen X, Bin Y Int J Clin Exp Pathol. 2016; 8(10):12977-94.

PMID: 26722494 PMC: 4680439.

References

Onat A, Hergenc G, Dursunoglu D, Ordu S, Can G, Bulur S . Associations of alcohol consumption with blood pressure, lipoproteins, and subclinical inflammation among Turks. Alcohol. 2008; 42(7):593-601. DOI: 10.1016/j.alcohol.2008.06.007. View

Cohen J, Pertsemlidis A, Kotowski I, Graham R, Garcia C, Hobbs H . Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet. 2005; 37(2):161-5. DOI: 10.1038/ng1509. View

Kiechl S, Willeit J, Rungger G, Egger G, Oberhollenzer F, Bonora E . Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke. 1998; 29(5):900-7. DOI: 10.1161/01.str.29.5.900. View

Kotowski I, Pertsemlidis A, Luke A, Cooper R, Vega G, Cohen J . A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet. 2006; 78(3):410-22. PMC: 1380285. DOI: 10.1086/500615. View

Benjannet S, Rhainds D, Essalmani R, Mayne J, Wickham L, Jin W . NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem. 2004; 279(47):48865-75. DOI: 10.1074/jbc.M409699200. View

McElduff P, Dobson A . How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ. 1997; 314(7088):1159-64. PMC: 2126495. DOI: 10.1136/bmj.314.7088.1159. View

Seidah N, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin S, Stifani S . The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A. 2003; 100(3):928-33. PMC: 298703. DOI: 10.1073/pnas.0335507100. View

Stampfer M, Krauss R, Ma J, Blanche P, Holl L, Sacks F . A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996; 276(11):882-8. View

Huang C, Fornage M, Lloyd-Jones D, Wei G, Boerwinkle E, Liu K . Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study. Circ Cardiovasc Genet. 2009; 2(4):354-61. PMC: 2810147. DOI: 10.1161/CIRCGENETICS.108.828467. View

10.

Maxwell K, Fisher E, Breslow J . Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc Natl Acad Sci U S A. 2005; 102(6):2069-74. PMC: 546019. DOI: 10.1073/pnas.0409736102. View

11.

Zhang D, Lagace T, Garuti R, Zhao Z, McDonald M, Horton J . Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J Biol Chem. 2007; 282(25):18602-18612. DOI: 10.1074/jbc.M702027200. View

12.

Hsu L, Teng M, Ko Y, Chang C, Wu S, Wang C . The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan. Clin Chem Lab Med. 2009; 47(2):154-8. DOI: 10.1515/CCLM.2009.032. View

13.

Ouguerram K, Chetiveaux M, Zair Y, Costet P, Abifadel M, Varret M . Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9. Arterioscler Thromb Vasc Biol. 2004; 24(8):1448-53. DOI: 10.1161/01.ATV.0000133684.77013.88. View

14.

Park S, Moon Y, Horton J . Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J Biol Chem. 2004; 279(48):50630-8. DOI: 10.1074/jbc.M410077200. View

15.

Gronbaek M, Deis A, Becker U, Hein H, Schnohr P, Jensen G . Alcohol and mortality: is there a U-shaped relation in elderly people?. Age Ageing. 1999; 27(6):739-44. DOI: 10.1093/ageing/27.6.739. View

16.

Savolainen M, Kesaniemi Y . Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol. 1995; 6(4):243-50. DOI: 10.1097/00041433-199508000-00009. View

17.

Camargo Jr C, Hennekens C, Gaziano J, Glynn R, Manson J, Stampfer M . Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med. 1997; 157(1):79-85. View

18.

Agarwal D . Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol. 2002; 37(5):409-15. DOI: 10.1093/alcalc/37.5.409. View

19.

Lambert G, Jarnoux A, Pineau T, Pape O, Chetiveaux M, Laboisse C . Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor. Endocrinology. 2006; 147(10):4985-95. DOI: 10.1210/en.2006-0098. View

20.

Rimm E, Williams P, Fosher K, Criqui M, Stampfer M . Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 319(7224):1523-8. PMC: 28294. DOI: 10.1136/bmj.319.7224.1523. View